Allergan to Buy MAP Pharmaceuticals for $958M

Allergan to Buy MAP Pharmaceuticals for $958M Play

Jan. 22 (Bloomberg) -- Allergan agreed to pay $25 per share for MAP Pharmaceuticals in what the companies called a “definitive merger agreement.” Matt Miller reports on Bloomberg Television's "Bloomberg Rewind." (Source: Bloomberg)

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus